Evidence map›Paper›PMID 26524488›Full record

ArticleAnnals of the American Thoracic Society2015

Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.

Carlos H Martinez, David M Mannino, Fabian A Jaimes, Jeffrey L Curtis, MeiLan K Han, Nadia N Hansel, Alejandro A Diaz

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07543601 (Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention), which is not on this map. Cited by 107 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 3 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07543601 narecruitingnot on this mapstarted 2026, after this paper: background citation

Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention

TypeinterventionalSponsorDitte Krag-HansenRan2026 to 2027Enrolled280ConditionsCOPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis), Lung Neoplasm Malignant, Lung CarcinomaArmsTailored COPD consultations
3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 3 syntheses or guidelines pooled it, 209 citations in OpenAlex.

  1. Pooled it
  2. Lung Cancer Risk in US Adults with COPD: A Systematic Review and Meta-Analysis.International journal of chronic obstructive pulmonary disease · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Observational
  10. Article
  11. Pre-COPD: Impact on prevention, detection, and treatment.Presse medicale (Paris, France : 1983) · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Prospective COPD Case Finding in a Lung Cancer Screening Program: A Pilot Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025
    Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Carlos H Martinez1 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.
David M Mannino2 Department of Preventive Medicine and Environmental Health, University of Kentucky College of Medicine, Lexington, Kentucky.
Fabian A Jaimes4 Department of Internal Medicine, University of Antioquia and Research Unit, Hospital Pablo Tobón Uribe, Medellin, Colombia.
Jeffrey L Curtis1 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.
MeiLan K Han1 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.
Nadia N Hansel6 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and.
Alejandro A Diaz7 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard University, Boston, Massachusetts.
Michigan Medicine · USBrigham and Women's Hospital · USJohns Hopkins Medicine · USUniversidad de Antioquia · COUniversity of Kentucky · USVA Ann Arbor Healthcare System · US

Funding

PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9M
Parametric Response Mapping in COPDR01HL122438 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAN, MEILAN K, MARTINEZ, FERNANDO J · 2014 to 2017
$4.0M
Design and Testing of tools to Identify individuals at high risk for COPD^ 73R01HL114055 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEIDY, NANCY KLINE, MANNINO, DAVID · 2012 to 2014
$2.4M
Computed Tomographic-Based Assessment of Airway Remodeling in COPDK01HL118714 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DIAZ, ALEJANDRO · 2013 to 2017
$783k
NHLBI NIH HHS 1R01HL122438-01NHLBI NIH HHS 3R01HL122438-02S1NHLBI NIH HHS K01 HL118714NHLBI NIH HHS K01HL118714NHLBI NIH HHS R01 HL114055NHLBI NIH HHS R01 HL122438NHLBI NIH HHS T32 HL007749
6 · The paper itself

Abstract

rationaleUnderstanding factors associated with undiagnosed obstructive lung disease and its impact on mortality could inform the ongoing discussions about benefits and risks of screening and case finding.

objectivesTo define factors associated with undiagnosed obstructive lung disease and its long-term mortality.

methodsCross-sectional analysis of participants, aged 20 to 79 years, in two National Health and Nutritional Examination Surveys (NHANES), NHANES III (1988-1994) and NHANES 2007-2012, with longitudinal follow-up of NHANES III participants. MEASUREMENTS AND MAIN

resultsWe classified participants with spirometry-confirmed obstructive disease, based on the fixed ratio definition (FEV1/FVC < 0.7), as "diagnosed" (physician diagnosis of either asthma or chronic obstructive pulmonary disease), and "undiagnosed" (no recorded physician diagnosis). For the longitudinal analysis of NHANES III participants, mortality was the outcome of interest. We tested the contribution of self-reported health status and comorbidity burden (exposure) to the odds of being undiagnosed using logistic models adjusted for demographics, smoking status, and lung function. We estimated hazard ratios (HRs) for all-cause mortality for diagnosed and undiagnosed subjects participating in NHANES III who had spirometry using Cox- proportional regression analysis. Among those with spirometry-defined obstruction, 71.2% (SE, 1.8) in NHANES III and 72.0% (SE, 1.9) in NHANES 2007-2012 were undiagnosed. In multivariate models, undiagnosed obstructive disease was consistently associated in both surveys with self-reported good/excellent health status, lower comorbidity burden, higher lung function, and being of racial/ethnic minority. Among NHANES III participants (median follow up, 14.5 yr), both undiagnosed (HR, 1.23; 95% confidence interval, 1.08-1.40) and correctly diagnosed participants (HR, 1.74; 95% confidence interval, 1.45-2.09) had higher risk for all-cause mortality than participants without obstruction.

conclusionsUndiagnosed obstructive lung disease is common among American adults and remained unchanged over 2 decades. Although undiagnosed subjects appear healthier than those with a diagnosis, their risk of death was increased compared with subjects without obstruction. These findings need to be considered when judging the implications of case-finding programs for obstructive lung disease.

Indexed as

Diagnostic ErrorsHealth StatusAdolescentAdultAgedAged, 80 and overChildCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedNutrition SurveysPrevalencePulmonary Disease, Chronic Obstructiveasthmachronic obstructive pulmonary diseasecomorbiditiesobstructive lung disease; health status

Identifiers

PMID26524488
PMCPMC4722830
OpenAlexW1951292309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.